Location: Greenwich, CT
CIK: 0001577524 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value: $899M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 643,000 | $172M | 19.1% | $278.12 | +8.1% | COM | 09062X103 |
| ALKS | ALKERMES PLC | 7,825,000 | $152M | 16.9% | $18.71 | -13.2% | SHS | G01767105 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 14,040,000 | $145M | 16.1% | $11.68 | -12.3% | COM CL A | 46333X108 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 928,100 | $102M | 11.4% | $128.37 | -13.9% | SHS USD | G50871105 |
| INVA | INNOVIVA INC | 6,414,000 | $89.67M | 10.0% | $13.01 | +4.6% | COM | 45781M101 |
| — | ALEXION PHARMACEUTICALS INC | 743,500 | $83.45M | 9.3% | $108.16 | — | COM | 015351109 |
| — | MERSANA THERAPEUTICS INC | 2,570,000 | $60.14M | 6.7% | $5.26 | — | COM | 59045L106 |
| — | INTERCEPT PHARMACEUTICALS INC | 1,201,000 | $57.54M | 6.4% | $79.88 | — | COM | 45845P108 |
| ABBV | ABBVIE INC | 310,150 | $30.45M | 3.4% | $70.40 | +0.1% | COM | 00287Y109 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,075,000 | $5.122M | 0.6% | $3.99 | 0.0% | COM | 09058V103 |
| — | REGULUS THERAPEUTICS INC | 1,851,851 | $1.262M | 0.1% | $1.25 | — | COM NEW | 75915K200 |
| — | MIRATI THERAPEUTICS INC | 1,000 | $114K | 0.0% | $42.00 | — | COM | 60468T105 |